cyproterone acetate has been researched along with Scleroderma, Systemic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battisti, E; Fattorini, L; Fioravanti, A; Giordano, N; Magaro, L; Marcolongo, R; Marcucci, P | 1 |
1 other study(ies) available for cyproterone acetate and Scleroderma, Systemic
| Article | Year |
|---|---|
Systemic sclerosis following anti-androgenic treatment for prostatic adenocarcinoma.
Topics: Adenocarcinoma; Androgen Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Cyproterone Acetate; Humans; Male; Methylprednisolone; Middle Aged; Orchiectomy; Prostatic Neoplasms; Scleroderma, Systemic | 1993 |